Effects of olmesartan and enalapril at low or high doses on cardiac, renal and vascular interstitial matrix in spontaneously hypertensive rats

References

• Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricle in experimental hypertension. Circ Res. 1990;67:1355–1364.
   Google Scholar
• Weber KT, Anversa P, Armstrong PW, Brilla CG, Burnett JC, Cruickshank JM, et al. Remodeling and reparation of the cardiovascular system. JACC. 1992;20:3–16.
   Google Scholar
• Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone. J Mol Cell Cardiol. 1994;26:809–820.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Porteri E, Piccoli A, Castellano M, Bettoni G, Muiesan ML, et al. Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension. 1998;32:305–310.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Rodella L, Porteri E, Rezzani R, Sleiman I, Paiardi S, et al. Effects of losartan and enalapril at different doses on cardiac and renal interstitial matrix in spontaneously hypertensive rats. Clin Exp Hypertens. 2003;25:427–441.
   PubMed Web of Science ®Google Scholar
• Mezzano S, Ruiz-Ortega M, Egidio I. Angiotensin II and renal fibrosis. Hypertension. 2001;38 (Pt2):635–638.
   Google Scholar
• Ichikawa I. Will angiotensin II receptor antagonists be renoprotective in humans? Kidney Int. 1996;50:684–692.
   Google Scholar
• Mannisto TK, Karvonen KE, Kerola TV, Ryhanen U. Inhibitory effect of the angiotensin converting enzyme inhibitors captopril and enalapril on the conversion of procollagen to collagen. J Hypertens. 2001;19:1835–1839.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Porteri E, Piccoli A, Castellano M, Muiesan ML, Pasini G, et al. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1998;32:798–806.
   PubMedGoogle Scholar
• Deyl Z, Jelinek J, Macek K, Chaldakov G. Vankov VN Collagen and elastin synthesis in the aorta of spontaneously hypertensive rats. Blood Vessels. 1987;24:313–320.
   PubMedGoogle Scholar
• Mizutani K, Ikeda K, Kawai Y, Yamori Y. Biochemical properties and chemical composition of the aorta in genetic hypertensive rats. J Hypertens. 1999;17:481–487.
   PubMedGoogle Scholar
• van Gorp AW, Schenau DS, Hoeks AP, Boudier HA, de Mey JG, Reneman RS. In spontaneously hypertensive rats alterations in aortic wall properties precede development of hypertension. Am J Physiol. 2000;278:H1241–H1247.
   Google Scholar
• Cox RH. Basis for altered arterial wall mechanics in the spontaneously hypertensive rats. Hypertension. 1981; 3:485–495.
   PubMed Web of Science ®Google Scholar
• Koffi I, Safar ME, Labat C, Lacolley P, Benetos A, Mourad JJ. Arterial structural changes with verapamil in spontaneously hypertensive rats. Am J Hypertens. 1999;12:732–738.
   PubMedGoogle Scholar
• Sugano M, Tsuchida K, Sawada S, Makin° N. Reduction of plasma angiotensin II to normal levels by antisense oligo-deoxynucleotides against liver angiotensinogen cannot com-pletely attenuate vascular remodelling in spontaneously hypertensive rats. J Hypertens. 2000;18:725–731.
   Google Scholar
• Brunner HR, Fujita T. Olmesartan: A new antagonist in cardiovascular risk prevention. J Human Hypertens. 2002;16 Suppl 2:S1–S2.
   Google Scholar
• Miyazaki M, Takai S. Anti-atherosclerotic efficacy of olmesartan. J Human Hypertens. 2002;16 Suppl 2:S7–S12.
   Google Scholar
• Brunner HR. The new oral angiotensin II antagonist olmesartan medoxomil: A concise overview. J Human Hypertens. 2002;16 Suppl 2:S17–S23.
   Google Scholar
• Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res. 1978;43:854–864.
   Google Scholar
• Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev. 1990;70:921–971.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti Rosei E. Delayed development of hypertension after short-term nitrendipine treatment. Hypertension. 1994;24:131–139.
   PubMed Web of Science ®Google Scholar
• Vecchione C, Frata L, Rizzoni D, Notte A, Poulet R, Porteri E, et al. Cardiovascular influences of (1B-adrenergic receptor in mice. Circulation. 2002105:1700-1707.
   PubMed Web of Science ®Google Scholar
• James J, Bosch KS, Zuyderhoudt FMJ, Houtkooper JM, van Gool J. Histophotometric estimation of volume density of collagen as an indication of fibrosis in rat liver. Histochemistry. 1986;85:129–133.
   Google Scholar
• Canham PB, Talman EA, Finlay HM, Dixon JD. Medial collagen organization in human arteries of the heart and brain by polarized light microscopy. Connective Tissue Res. 1991;26:121–134.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Rossi GP, Porteri E, Sticchi E, Rodella L, Rezzani R, et al. Bradykinin and matrix metalloproteinases are involved in prevention of structural alterations of rat small arteries during inhibition of ACE and NEP. J Hypertens. 2004;22:1–8.
   Google Scholar
• Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone. J Mol Cell Cardiol. 1994;26:809–820.
   PubMed Web of Science ®Google Scholar
• Dostal DE. Regulation of cardiac collagen. Angiotensin and cross-talk with local growth factors. Hypertension. 2001;37:841–844.
   Google Scholar
• Brilla CG, Zhou G, Matsubara L, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation. 1991;83:1771–1779.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Cinelli A, et al. Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Hypertension. 1995;26:118–123.
   PubMed Web of Science ®Google Scholar
• Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries Circ Res. 1991;69:107–117.
   Google Scholar
• Francischetti A, Ono H, Frohlich ED. Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME. Hypertension. 1988;31:795–801.
   Google Scholar
• Casellas D, Benhamed S, Artuso A, Jover B. Candesartan and progression of preglomerular lesions in L-NAME hyperten-sive rats. J Am Soc Nephrol. 1999;10:5230–5233.
   Google Scholar
• Michel JB, Xu Y, Blot S, Philippe M, Chatellier G. Improved survival in rats administered L-NAME due to converting enzyme inhibition. J Cardiovasc Pharmacol. 1996; 28:142–148.
   Google Scholar
• Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti Rosei E. Delayed development of hypertension after short-term nitrendipine treatment. Hypertension. 1994; 24:131–139.
   PubMed Web of Science ®Google Scholar